NCT06557330 2025-01-06MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin LymphomaFox Chase Cancer CenterPhase 2 Not yet recruiting24 enrolled
NCT06573645 2024-08-27A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCLSun Yat-sen UniversityPhase 3 Not yet recruiting428 enrolled